Chromosomal Instability in Chromosome Band 12P13

Chromosomal Instability in Chromosome Band 12P13

Leukemia (2001) 15, 1193–1202 2001 Nature Publishing Group All rights reserved 0887-6924/01 $15.00 www.nature.com/leu Chromosomal instability in chromosome band 12p13: multiple breaks leading to complex rearrangements including cytogenetically undetectable sub-clones Y Sato1, H Kobayashi2, Y Suto3, HJ Olney4, EM Davis4, H Gill Super4, R Espinosa III4, MM Le Beau4 and JD Rowley4 1Division of Molecular Cytogenetics, Department of Clinical Pathology, Research Institute of International Medical Center of Japan, Tokyo; 2Hematologic Clinic, Saitama Cancer Center Hospital, Saitama; 3Department of Pediatrics, Aomori Municipal Hospital, Aomori, Japan; and 4University of Chicago, Department of Medicine, Section of Hematology/Oncology, Chicago, IL, USA During fluorescence in situ hybridization (FISH) analysis of 12p12–13 are also detected in non-small cell lung cancer, metaphase cells from 70 patients with lymphoid and myeloid breast cancer, and ovarian cancer, where the common hematologic malignancies and chromosomal rearrangements involving band 12p13, we identified nine patients (four with deleted region again includes the TEL to KIP1 interval. In an lymphoid malignancies, four with myeloid malignancies and attempt to clone potential tumor suppressor genes (TSGs) on one with biphenotypic leukemia) who showed more compli- this region, Baens et al20 further refined the common deleted cated rearrangements than we had expected from conventional segment to 600 kb between TEL and D12S358, excluding cytogenetic study. In six patients, multiple breaks occurred in KIP1. small segments of 12p with subsequent translocations and While examining the breakpoint in 23 patients with bal- insertions of these segments into other chromosomes, some- 21 times to unexpected regions. In three patients additional chro- anced translocations involving 12p13 and defining the com- mosome breaks resulted in a sub-clone which was cytogenet- monly deleted region in 47 patients with unbalanced translo- ically indistinguishable from the main clone in each patient cations or deletions involving band 12p13 with FISH,19 we based on the cytogenetic analysis. These subtle molecular found nine patients with multiple chromosomal breaks in 12p. events were detected exclusively in a region covering Similar molecular events have been reported in a few TEL/ETV6 and KIP1/CDKN1B. Seven of nine had a previous his- patients.22,23 tory of chemo/radiotherapy; all the patients showed complex karyotypes, even though they were newly diagnosed with leu- In this report, we tried to delineate clinical and cytogenetic kemia. Survival data were available in five patients, and all sur- characteristics of these patients in comparison with previously vived less than 6 months. These findings suggest that the reported patients. Whereas such events have been reported 12p13 region, especially the above-mentioned region, is geneti- only in myeloid malignancies so far, our patient series cally unstable and fragile. It is likely that multiple chromosome included four lymphoid malignancies, four myeloid malig- breaks were induced through mutagens used in chemo/ nancies and one biphenotypic leukemia. In six patients, these radiotherapy, and are associated with a sub-group of patients with an extremely bad prognosis. Leukemia (2001) 15, 1193– multiple chromosomal breaks resulted in a deletion of a small 1202. segment and/or translocation of this segment to another chro- Keywords: 12p13 rearrangements; hematologic malignancies; mosome, sometimes to unexpected regions. In three patients, FISH; chromosomal instability; TEL/ETV6; KIP1/CDKN1B additional chromosome breaks occurred in some of the cells; the karyotype of the sub-clone was indistinguishable at the standard chromosome analysis level from that of the main Introduction clone in each patient. These molecular events were exclus- ively found in a region covering TEL and KIP1, whereas others Rearrangements of the short arm of chromosome 12 (12p) were found in the telomeric region to TEL.22 These findings have been found in a wide spectrum of hematologic malig- suggest that this region is genetically unstable and fragile, nancies and solid tumors.1–5 Although each band of 12p leading to these complex genetic events. All the patients had a (12p11, 12p12, and 12p13) is rearranged in various types of complex karyotype, even though they were newly diagnosed. abnormalities including balanced or unbalanced trans- Survival data were available in five, and all survived less than locations, insertions, inversions and deletions, rearrangements 6 months. Thus, patients with multiple chromosomal breaks of band 12p13 are most frequently observed.6 TEL/ETV6 and in this region have an extremely bad prognosis. KIP1/CDKN1B are located in this band. TEL is a transcription factor identified by Golub et al7 as a partner gene of PDGFRB in a patient with a t(5;12)(q33;p13). Since then, TEL has been Materials and methods reported to fuse to several tyrosine kinases (ABL,8,9 ARG,10 JAK211,12 and TRKC13–16), a transcription factor (AML117) and Patients unrelated transcription factors. To date, 41 chromosomal bands have been demonstrated to be involved in TEL translo- Patients were referred to the Section of Hematology/Oncology cations.18 at the University of Chicago for chromosome study from 1970 Previously, we reported that the smallest commonly deleted to 1994. Selection of patients was based on diagnosis of a region found in hematologic malignancies with 12p12–13 hematologic malignancy and the presence of 12p12–13 deletions was flanked by TEL at the telomeric side and KIP1 rearrangements in the karyotype. Seventy patients were selec- at the centromeric side.19 Moreover, deletions of bands ted (47 patients with unbalanced translocations or deletions19 and 23 patients with balanced translocations21). These cases included 20 lymphoid malignancies (14 acute lymphocytic leukemia (ALL), one chronic lymphocytic leukemia (CLL) and Correspondence: Y Sato, Division of Molecular Cytogenetics, Depart- five non-Hodgkin’s lymphoma (NHL)), 49 myeloid malig- ment of Clinical Pathology, Research Institute, International Medical Center of Japan, Toyama 1-21-1, Shinjuku-Ku, Tokyo, 162-0052, nancies (four acute leukemia (AL) or acute undifferentiated Japan; Fax: 81-3-5273-8602 leukemia (AUL), 16 acute myelogenous leukemia (AML), five Received 18 January 2001; accepted 17 April 2001 therapy-related AML (t-AML), four chronic myelogenous leu- Chromosomal instability in band 12p13 Y Sato et al 1194 kemia (CML), three myelofibrosis (MF), one polycythemia vera FISH study (PV), 13 myelodysplastic syndrome (MDS), and three t-MDS), and one biphenotypic leukemia. Patient material submitted for The probes were labeled with biotin-11-dUTP or digoxigenin- cytogenetic analysis during this period had the following diag- 11-dUTP using nick translation and were hybridized to chro- nostic breakdown: 918 ALL, 202 CLL/prolymphocytic leuke- mosome preparations as previously described.28 Chromo- mia, 107 hairy cell leukemia, 1566 NHL, 147 unclasified or somal bands were identified using counterstaining with 4Ј 6- biphenotypic leukemia, 2117 AML, 1605 myeloproliferative diamindino-2-phenylindole dihydrochloride (DAPI). The pres- disorders (MPD) (including 880 CML, 143 FM, 185 PV, 58 ence or absence of the FISH signals was scored on an average essential thrombocythemia and 347 other/unclassified MPD), of 10.7 abnormal metaphase cells (range 3–20) per probe per 1454 MDS, and 496 t-AML/MDS cases. All t-AML/MDS patient by two persons blinded to the identity of probes and patients are double counted also being included in either the patients. Images of the hybridizations were captured with a AML or MDS categories; 118 patients had both AML and MDS liquid-cooled, charge-coupled device camera (Photometrics, diagnoses and eight MPD patients have more than one MPD Tucson, AZ, USA). Separate gray-scale images for the DAPI diagnosis included at some point in laboratory records. and the fluorescein isothiocyanate (FITC) or rhodamine fluor- The disease stage when the samples were obtained was as ochromes were acquired. After adjusting the gray levels with follows: among 20 lymphoid malignancies, 14 cases were at the National Institutes of Health (NIH, Bethesda, MD, USA) diagnosis and six at relapse, whereas among 49 myeloid image 1.61 software, the images were merged using Adobe malignancies, 33 were at diagnosis and 16 at relapse. While Photoshop (Adobe System, San Jose, CA, USA) on a Macintosh performing FISH analysis, we identified nine patients who computer (Apple Computer, Cupertino, CA, USA). showed multiple chromosome breaks in 12p13. There were four males and five females aged between 2 and 81. Three were diagnosed as having ALL, three had MDS, and one each Results had NHL, t-AML and biphenotypic leukemia when the chromosomal samples were obtained (Table 1). All of the All the patients showed complex karyotypes patient samples were obtained with informed consent. Clinical data including previous history, treatment and sur- vival and cytogenetic findings of the nine patients are summa- rized in Table 1. All patients were studied a long time ago, Cytogenetic analysis and thus some clinical data were impossible to collect. Two (patients 1 and 9) had newly diagnosed leukemia and for Metaphase cells were prepared for cytogenetic study as pre- whom a previous history of environmental exposure was viously described.24 The karyotypes were described according unknown: the remaining patients had a history of treatment for to the International

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    10 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us